Home
Regenxbio RGNX paid LMH Strategic Solutions $60K for lobbying in Q1 2026 · Pharmacy, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q1 2026
- Stock
- Regenxbio RGNX
- Client
- Regenxbio
- Reported
- 26/04/17
Up 0.0% from last quarter
What else happened in Regenxbio around then
Filed or reported within 30 days of the trade day · 03/01~04/30Regenxbio's other lobbying reports
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 07/20
for Q2
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 07/17
for Q2
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 07/05
for Q2
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 04/20
for Q1
- Regenxbio
LobbyingRegenxbio
LobbyingRegenxbio
RGNX
$60K
$60K
Reported 04/16
for Q1